OBJECTIVE: The effect of mHTT on human development was examined by evaluating measures of growth in children at risk for Huntington disease (HD). METHODS: Children at risk for HD with no manifest symptoms (no juvenile HD included) were enrolled and tested for gene expansion for research purposes only. Measurements of growth (height, weight, body mass index [BMI], and head circumference) in children tested as gene-expanded (n = 20, 7-18 years of age, CAG repeats ≥39) were compared to those of a large database of healthy children (n = 152, 7-18 years of age). RESULTS: Gene-expanded children had significantly lower measures of head circumference, weight, and BMI. Head circumference was abnormally low even after correcting for height, suggesting a specific deficit in brain growth, rather than a global growth abnormality. CONCLUSIONS: These results indicate that, compared to a control population, children who were estimated to be decades from HD diagnosis have significant differences in growth. Further, they suggest that mHTT may play a role in atypical somatic, and in particular, brain development.
OBJECTIVE: The effect of mHTT on human development was examined by evaluating measures of growth in children at risk for Huntington disease (HD). METHODS:Children at risk for HD with no manifest symptoms (no juvenile HD included) were enrolled and tested for gene expansion for research purposes only. Measurements of growth (height, weight, body mass index [BMI], and head circumference) in children tested as gene-expanded (n = 20, 7-18 years of age, CAG repeats ≥39) were compared to those of a large database of healthy children (n = 152, 7-18 years of age). RESULTS: Gene-expanded children had significantly lower measures of head circumference, weight, and BMI. Head circumference was abnormally low even after correcting for height, suggesting a specific deficit in brain growth, rather than a global growth abnormality. CONCLUSIONS: These results indicate that, compared to a control population, children who were estimated to be decades from HD diagnosis have significant differences in growth. Further, they suggest that mHTT may play a role in atypical somatic, and in particular, brain development.
Authors: A Lamerz; J Kuepper-Nybelen; C Wehle; N Bruning; G Trost-Brinkhues; H Brenner; J Hebebrand; B Herpertz-Dahlmann Journal: Int J Obes (Lond) Date: 2005-04 Impact factor: 5.095
Authors: William J Powers; Tom O Videen; Joanne Markham; Lori McGee-Minnich; Joann V Antenor-Dorsey; Tamara Hershey; Joel S Perlmutter Journal: Proc Natl Acad Sci U S A Date: 2007-02-13 Impact factor: 11.205
Authors: Peter M Visscher; Sarah E Medland; Manuel A R Ferreira; Katherine I Morley; Gu Zhu; Belinda K Cornes; Grant W Montgomery; Nicholas G Martin Journal: PLoS Genet Date: 2006-03-24 Impact factor: 5.917
Authors: Benjamin R Underwood; David Broadhurst; Warwick B Dunn; David I Ellis; Andrew W Michell; Coralie Vacher; David E Mosedale; Douglas B Kell; Roger A Barker; David J Grainger; David C Rubinsztein Journal: Brain Date: 2006-02-07 Impact factor: 13.501
Authors: P Conforti; D Besusso; V D Bocchi; A Faedo; E Cesana; G Rossetti; V Ranzani; C N Svendsen; L M Thompson; M Toselli; G Biella; M Pagani; E Cattaneo Journal: Proc Natl Acad Sci U S A Date: 2018-01-08 Impact factor: 11.205
Authors: Oliver W J Quarrell; Martha A Nance; Peggy Nopoulos; Jane S Paulsen; Jonathan A Smith; Ferdinando Squitieri Journal: Neurodegener Dis Manag Date: 2013-06-01
Authors: Carissa E Hunter; Alvince L Pongos; Tim Y Chi; Christa Payne; Fawn C Stroud; Anthony W S Chan Journal: Comp Med Date: 2018-04-02 Impact factor: 0.982
Authors: Laurent Younes; J Tilak Ratnanather; Timothy Brown; Elizabeth Aylward; Peg Nopoulos; Hans Johnson; Vincent A Magnotta; Jane S Paulsen; Russell L Margolis; Roger L Albin; Michael I Miller; Christopher A Ross Journal: Hum Brain Mapp Date: 2012-12-20 Impact factor: 5.038